Sort   by:  
 Page size 
UnknownThe efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.
Not available
S-EPMC7528953 | biostudies-literature
UnknownTumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.
Not available
S-EPMC8020996 | biostudies-literature
UnknownOutcomes of COVID-19 in patients with CLL: a multicenter international experience.
Not available
S-EPMC7472711 | biostudies-literature
UnknownOutcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.
Not available
S-EPMC11842760 | biostudies-literature
UnknownCOVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Not available
S-EPMC8313815 | biostudies-literature
UnknownAssessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.
Not available
S-EPMC8588795 | biostudies-literature
UnknownBreast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.
Not available
S-EPMC3387216 | biostudies-literature
Sort   by:  
 Page size